Icon

NASCOBAL - (0.5mg/Spray; Spary, Metered, Nasal)

CYANOCOBALAMIN Endo Pharma
0.5mg/Spray; Spary, Metered, Nasal
Less Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
None
Less Than 5
Less Than 5
Indicated for the maintenance of normal hematologic status in pernicious anemia patients who are in remission following intramuscular vitamin B12 therapy and who have no nervous system involvement.
Yes
***** ***** ** ** *** **** ** ****** **** ******** ** *** ****. ***** ********* **** ** ************* *** *******, *******, ******* (*** ******** ** *** *, ****), ******* (*** **, ****), ******* (*** **, ****), ******* (*** **, ****) - ** ******* *** *** **** ** ****.
NASCOBAL Patent 1 Patent 2 Patent 3 Patent 4 Patent 5 Patent 6
***** **** ** ** (*******) **** ** ** (*******) **** ** ** (*******) **** ** ** (*******) **** ** ** (*******) **** ** ** (*******)
******* **** ** ** (*******) **** ** ** (*******) **** ** ** (*******) **** ** ** (*******) **** ** ** (*******) **** ** ** (*******)
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
***** *** \ ** *** **, **** ******* ***** **** ** ** ******** ******** ** *** **, ****
******* ** \ ** **** *, **** ******* ***** **** ** ** **** ******* *** **** *** *** ****
  1. *** **, **** : ***** ******** ********* **** ** ************* ******* *******, *******, ******* (*** ******** ** *** *, ****), ******* (*** **, ****), ******* (*** **, ****), ******* (*** **, ****) - ** *******.
  2. *** **, **** : **** **** ***** ** ** ** *****.
  3. *** *, **** : **** ***** * **** ****** ******* ** *** *******.
  4. *** **, **** : **** ******* **** ***** *** ** ***** **** ***** *** ********* *** *** *******
  5. *** **, **** : **** ******* **** ******* *** ** ***** **** ******* *** ********* *** *** *******

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.